Associate Professor Nikola Bowden, a Translational Cancer Researcher and member of ANZGOG's Ovarian Tumour Type Working Group, tells us a little about herself and speaks about her own research and how she contributes to ANZGOG's research. [...]
Part of ANZGOG's OASIS initiative, the IGNITE clinical trial seeks to obtain important clinical data on high-grade serous ovarian cancer treatment. Dr. George Au-Yeung is a medical oncologist at the Peter MacCallum Cancer Center [...]
Associate Professor Tarek Meniawy, Chair of the ANZGOG Ovarian Tumour Working Group, shares updates from the recent meeting of ANZGOG researchers, discussing new and ongoing ovarian cancer therapy studies. Associate Professor Tarek Meniawy is a [...]
ANZGOG, as part of its member education activities, is presenting an Education Webinar Series for ANZGOG members and others across the health sector. Chaired by two ANZGOG members, Professor Andreas Obermair and Associate Professor Tarek Meniawy. [...]
Australian women will now have affordable access to Lynparza (Olaparib) for ovarian cancer maintenance treatment after the drug was included in the latest PBS list. Treasurer Josh Frydenberg's budget speech on Tuesday announced that from [...]
The study funded by the Medical Research Future Fund will attempt to seek greater treatment outcomes for women affected by ovarian cancer. Principal Investigator Associate Professor Rhonda Farrell speaks about the study aims. The study [...]
Celebrating her ten-year survival milestone during #GynaecologicalCancerAwarenessMonth, Consumer Research Panelist, Lisa Finucane, advocates for ovarian cancer awareness and pioneering research to hopefully one day find a cure. Lisa was diagnosed with Stage 3 Low [...]
Awarded a $2m Medical Research Future Fund government grant for the PARAGON-II study, Principal Investigator Associate Professor Chee Lee speaks about the study aims. The study follows on from PARAGON, an ANZGOG trial that pioneered [...]
“We now know that women with the most common types of ovarian cancer should be offered genetic testing, irrespective of family history. So that's a significant change in the Australian guidelines and guidelines elsewhere. PARP inhibitors have [...]
ANZGOG congratulates its members Prof Linda Mileshkin, A/Prof Rhonda Farrell, and A/Prof Chee Khoon Lee for their successful MRFF grant initiatives in reproductive and gynaecological cancers. $6.5 million in funding will be invested by the [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
